SS Innovations International Presents at MoneyShow Virtual Expo

“The Progression of Surgical Robotics: Introducing the SSi Mantra System” Video Presentation Now Available for Viewing

FORT LAUDERDALE, FL, June 09, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – SS Innovations International, Inc. (the “Company” or “SS Innovations”) (OTC: SSII), a developer of innovative surgical robotic technologies dedicated to making robotic surgery affordable and accessible to a global population, today announced that it presented at the MoneyShow Virtual Expo for Accredited Investors held on June 6-7, 2023.

Dr. Sudhir Srivastava, Chairman of the Board and Chief Executive Officer of SS Innovations, and a pioneer in robotic cardiothoracic surgery, gave a presentation introducing the Company’s flagship SSI Mantra surgical robotic system. The innovative system is currently being utilized to perform successfully in a wide array of surgical specialties including Cardiovascular, Thoracic, Head and Neck, Gynecology, Urology, General Surgery, and very complex robotic cancer operations.  To date, more than 200 surgeries and 35 different types of surgical procedures across every specialty have been performed using the SSi Mantra system. Global demand is growing for surgical robots which allow surgeons to perform complex surgery with more precision and smaller incisions, leading to less pain, minimal blood loss, reduced risk of infection and faster recovery.

The presentation is now available for viewing at  The Progression of Surgical Robotics Introducing the SSi Mantra System.mp4 - Google Drive or on YouTube at The Progression of Surgical Robotics Introducing the SSi Mantra System - YouTube

About SS Innovations International, Inc.

SS Innovations International, Inc. (OTC: SSII) is a developer of innovative surgical robotic technologies with a vision to make the benefits of robotic surgery affordable and accessible to a larger part of the global population. SSII’s product range includes its proprietary “SSI Mantra” surgical robotic system, and “SSI Mudra”, its wide range of surgical instruments capable of supporting a variety of surgical procedures including robotic cardiac surgery. SSII’s business operations are headquartered in India and SSII has plans to expand the presence of its technologically advanced, user-friendly, and cost-effective surgical robotic solutions, globally. For more information, visit SSII’s website at www.ssinnovations.com or LinkedIn for updates.

Forward-Looking Statements

This press release may contain statements that are not historical facts and are considered forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995. The words “anticipate,” “assume,” “believe,” “estimate,” “expect,” “will,” “intend,” “may,” “plan,” “project,” “should,” “could,” “seek,” “designed,” “potential,” “forecast,” “target,” “objective,” “goal,” or the negatives of such terms or other similar expressions to identify such forward-looking statements. These statements relate to future events or SS Innovations International’s future financial performance and involve known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity, performance or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements.

For more information:
PCG Advisory
Stephanie Prince
sprince@pcgadvisory.com
(646) 863-6341